Chronic fatigue syndrome: a literature review from a physiatric perspective.
Jain, S S, DeLisa, J A · American journal of physical medicine & rehabilitation · 1998 · DOI
Quick Summary
This review examined over 200 scientific studies about ME/CFS to understand what we know about the condition, particularly focusing on thinking problems and exercise. The authors found that while patients often report cognitive difficulties, actual measured problems are subtle and mainly affect how quickly the brain processes complex information. Brain imaging studies suggest changes may occur in the white matter of the brain rather than in the muscles themselves.
Why It Matters
This review synthesizes early evidence that ME/CFS may involve brain changes rather than simple muscle weakness, supporting the biological basis of the condition and validating patient-reported cognitive symptoms. It highlights the critical need for better research methodology and careful study of exercise effects, directly informing how clinicians should approach both diagnosis and treatment recommendations for ME/CFS patients.
Observed Findings
Cognitive deficits in CFS are commonly reported by patients but measured impairments are subtle, specifically affecting complex information processing speed and efficiency
Neuroimaging studies (MRI, SPECT) and neuroendocrine research present preliminary evidence of white matter involvement in the brain
Weakness and fatigue may result from central nervous system alterations rather than peripheral muscle damage
Autonomic symptoms including orthostatic intolerance and syncope appear in some CFS patients
It is difficult to distinguish documented weakness and endurance deficits from deconditioning effects
Inferred Conclusions
CFS may represent multiple distinct diseases or multiple stages of a single disease process
Central nervous system involvement, particularly white matter pathology, may be a key mechanism in CFS rather than primary muscle dysfunction
Autonomic dysfunction in CFS could stem from cardiovascular deconditioning, postviral autonomic neuropathy, or a combination of both
Future research must use standardized diagnostic criteria and carefully controlled study designs to understand the relationship between neuropathology, psychological factors, and cognitive function in CFS
Remaining Questions
What This Study Does Not Prove
This literature review does not definitively prove what causes ME/CFS or establish whether cognitive deficits are caused by central nervous system changes versus deconditioning, as the authors themselves note these remain difficult to separate. The review does not establish clear diagnostic criteria for ME/CFS or demonstrate that exercise uniformly exacerbates or improves the condition. As a narrative review rather than a systematic analysis, it does not quantify the strength of evidence across studies or account for publication bias.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Is ME/CFS a single disease entity or multiple distinct conditions, and can we identify reliable biomarkers to differentiate subgroups?
How do we definitively separate the cognitive deficits and weakness caused by central nervous system pathology from those resulting simply from deconditioning?
Does exercise exacerbate ME/CFS symptoms in some patients, improve them in others, or both depending on disease subtype or stage?
What is the specific nature and location of white matter involvement observed on neuroimaging, and what does it mean functionally for patients?